BioSpace News Archive

Ovid Therapeutics Inc. today announced leadership appointments intended to enhance the execution of its corporate strategy and the scientific stewardship of its therapeutic development programs.

Recce Pharmaceuticals Limited (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to provide a notice of change of interests in Director holdings.

Evommune, Inc. today announced the closing of an additional $7.5 million to its Series B financing from new investor Verition Fund Management, bringing the total raised in the Series B round to $57.5 million.

SIVAD Diagnostic Medical Group LLC (SIVAD) today announced the launch of HarmGuard FX in Delaware, the first state in the nation to distribute this groundbreaking approach to reducing overdose deaths.

Recently, Sanyou Biopharmaceuticals Co., Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd., signed a license agreement for a collaboratively developed therapeutic biological product.

Synthego, a leading genome engineering company, is pleased to announce a groundbreaking partnership with ATCC.

The New Hope Research Foundation and Forge Biologics announced today a development and cGMP manufacturing partnership to advance the Foundation’s novel gene therapy, NHR01, into Phase I/II clinical trials for patients with GM2 gangliosidosis,

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Gibco™ OncoPro™ Tumoroid Culture Medium Kit *, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications.

Sinoveda is a health brand that is bringing innovative, herbally-based precision to drug discovery.

THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced the second investment of $5 million dollars in THINK Surgical by David Dvorak.